Par Pharmaceutical develops, manufactures and markets safe, innovative and cost-effective generic pharmaceutical products. The Par portfolio includes sterile injectable products, distributed by Par Sterile Products. Par Pharmaceutical is an operating company of Endo International plc (NASDAQ: ENDP) (TSX: ENL), a global specialty pharmaceutical company. Learn more at www.parsterileproducts.com